RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--In response to evolving needs expressed by the patient community and healthcare providers, effective immediately, Talecris Biotherapeutics, Inc. (http://www.talecris.com) has implemented a Portability Policy for Gamunex®. This policy better reflects and responds to current market dynamics by accommodating changes in customer relationships, sites of service and points of care. Talecris’ goal in implementing the Portability Policy for Gamunex is to help ensure patients who rely upon Gamunex continue to receive it reliably and at their preferred location in situations where their product supply channels or sources of distribution have changed.
